Gene expression profiles of hepatoma cell line HLE

Table 1 Genes differentially expressed between hepatoma cell line HLE and normal liver tissues generated by AtlasImage software (Version 1.01a)

Gene	Ratio	Difference	Protein/gene
F6k	0.361	-7908	TDGF1 + TDGF2 + TDGF3
B7g	0.412	-9606	SKY (DTK) (TYRO3) (RSE)
A5b	0.484	-8262	ERK activator kinase 1; MAPK/ERK kinase 1 (MEK1)
C5f	0.487	-8154	Epidermal growth factor receptor substrate (eps15)
E5b	0.504	-14946	Rho GDP-dissociation inhibitor 1
D6c	0.662	-10998	Semaphorin E
B7j	0.664	-12474	Tyrosine-protein kinase ABL2 ; tyrosine kinase ARG (ABLL)
F5l	0.732	-12132	Leukocyte interferon-inducible peptide
B2g	1.237	10252	TRAF-interacting protein (TRIP)
B3h	1.241	10508	Caspase-8 precursor; MACH; FLICE; (CAP4) (CASP8)
D5f	1.363	12000	CD9
C7l	1.381	14882	Retinoic acid receptor gamma
A3i	1.387	14088	CDK inhibitor p19INK4d
C7m	1.401	13224	Retinoid X receptor beta (RXR-beta)
C6n	1.444	11820	Sex gene
D3e	1.52	17176	Vitronectin precursor; serum spreading factor;
D4b	1.61	16212	Integrin alpha8
D2n	1.692	19718	TENASCIN-R
C1a	1.804	15096	DNA-dependent protein kinase (DNA-PK)
A4j	2.008	17856	Extracellular signal-regulated kinase 6 (ERK6) (ERK5)
D1b	2.038	20026	Byglycan
A7d	2.06	18522	Type II cytoskeletal 11 keratin; cytokeratin 1 (K1; CK 1);
A2k	2.061	18084	Cyclin C G1/S-specific
D4j	2.178	27156	Integrin beta7
D4k	2.252	28122	Integrin beta8
A7g	2.257	13428	Type II cytoskeletal 4 keratin; cytokeratin 4 (K4; CK4)
D1a	2.31	29184	Cartilage-specific proteoglycan core protein
			(CSPCP); aggrecan1
A5i	2.418	10668	E2F-3
B4d	2.474	11814	Akt1; rac protein kinase alpha; protein kinase B; c-Akt
A5l	4.256	37824	DP2 dimerization partner of E2F